Strategic Initiative

Slingshot members are tracking this corporate initiative:

TG Therapeutics (TGTX) and Novimmune Announce Global Agreement for Development and Commercialization of a Novel Anti-CD47/ Anti-CD19 Bispecific Antibody

Source Link:
http://ir.tgtherapeutics.com/news-releases/news-release-details/tg-therapeutics-and-novimmune-sa-announce-global-agreement

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TGTX
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Jun 20, 2018
Projected Implementation:
Q3, 2018
Relevance Tracked Until:
Q4, 2018
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Anti-cd47, Anti-cd19
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.